{"denomUnitsSelected":"Participants","description":"Genetic abnormalities are assessed at baseline and longitudinally during treatment as well as after treatment. Distribution of genetic abnormalities are reported.","reportingStatus":"NOT_POSTED","timeFrame":"Assessed at baseline, and 3, 6, 12, 15, 18, 24, 36 months","title":"Distribution of Genetic Abnormalities Before and After Treatment","type":"OTHER_PRE_SPECIFIED"}